中耳胆脂瘤骨质破坏机制研究进展

doi:10.3760/cma.j.issn.1007-1245.2024.19.008

摘要/Abstract

摘要：

中耳胆脂瘤是角化的鳞状上皮脱落后在中耳内形成的囊性结构，为非真性肿瘤，其临床表现与化脓性中耳炎相似，主要为耳流脓、听力下降、眩晕及耳痛等症状。严重者可以压迫周围骨质，造成破坏性骨吸收，引起一系列并发症，严重影响患者健康及预后。近些年，基质金属蛋白酶、核因子κB受体活化因子配体/骨保护素、炎症因子、巨噬细胞和角质细胞生长因子在中耳胆脂瘤骨质破坏中的作用越来越受到人们的关注。本文对中耳胆脂瘤骨质破坏机制研究进展作一综述。

关键词:

基质金属蛋白酶, 胆脂瘤, 核因子κB受体活化因子配体, 炎症, 巨噬细胞, 角质细胞生长因子, 进展

Abstract:

Middle ear cholesteatoma is a cystic structure that develops in the middle ear following the desquamation of keratinized squamous epithelium, and it should be noted that it is not a true neoplasm. Its clinical manifestations bear resemblance to those observed in chronic suppurative otitis media, primarily encompassing otorrhea, hearing impairment, vertigo, otalgia, etc. In severe cases, it can exert pressure on the surrounding bones, leading to destructive bone resorption and an array of complications that significantly impact patients' health and prognosis. Currently, the etiology of middle ear cholesteatoma remains elusive. The pathogenesis underlying bone destruction caused by this condition is multifaceted. In recent years, there has been growing attention toward the pivotal roles played by matrix metallo-proteinases, receptor activator of nuclear factor-κB ligand of osteoclasts /osteoprotegerin, inflammatory factors, macrophage, and keratinocyte growth factor in mediating bone destruction associated with middle ear cholesteatoma. This article provides an overview of the expression patterns exhibited by these aforementioned molecules in middle ear cholesteatoma as well as their contributions to bone destruction.

Key words:

Matrix metallo-proteinases, Cholesteatoma, Receptor activator of nuclear factor-κB ligand, Inflammation, Microphages, Keratinocyte growth factor

刘雪华张肖林李长叶王延飞.

中耳胆脂瘤骨质破坏机制研究进展 [J]. 国际医药卫生导报, 2024, 30(19): 3203-3207.

Liu Xuehua, Zhang Xiaolin, Li Changye, Wang Yanfei.

Research progress on mechanism of bone destruction in middle ear cholesteatoma [J]. International Medicine and Health Guidance News, 2024, 30(19): 3203-3207.

参考文献

[1] 费永光,岑瑞祥. 耳内镜下应用纳吸棉联合布地奈德混悬液在Ⅰ型鼓室成形术中的临床疗效分析[J]. 国际医药卫生导报,2022,28(14):1959-1964.DOI:10.3760/cma.j.issn.1007-1245.2022.14.008.
[2] 赵昱,郭霞,刘汝利. MMP-2与RANKL在外耳道胆脂瘤骨质破坏中的研究进展[J/CD]. 世界最新医学信息文摘(连续型电子期刊),2018,18(80):49-51.DOI:10.19613/j.cnki. 1671-3141.2018.80.021.
[3] 赵昱. RANKL及MMP-2在外耳道胆脂瘤中的表达及相关性研究[D]. 唐山:华北理工大学,2019.
[4] Morita Y, Yamamoto Y, Oshima S, et al. Acquired cholesteatoma in children: clinical features and surgical outcome[J].Auris Nasus Larynx,2014,41(5):417-421.DOI:10.1016/j.anl.2014.05.002.
[5] Kan T, Ueda H, Takahara T, et al. Association of matrix metalloproteinase-2 mRNA expression with subtypes of pediatric cholesteatoma[J].Biomed Res Int,2021,2021:6644897.DOI:10.1155/2021/6644897.
[6] 苏秋豫. 儿童和成人后天性中耳胆脂瘤的临床特点分析[D]. 郑州:郑州大学,2019.
[7] Fang L, Chen L, Lin B, et al. Analysis of inflammatory and homeostatic roles of tissue-resident macrophages in the progression of cholesteatoma by RNA-Seq[J].Immunol Invest,2021,50(6):609-621.DOI:10.1080/08820139. 2020.1781161.
[8] Palkó E, Póliska S, Sziklai I, et al. Analysis of KRT1, KRT10, KRT19, TP53 and MMP9 expression in pediatric and adult cholesteatoma[J].PLoS One,2018,13(7):e0200840.DOI:10.1371/journal.pone.0200840.
[9] Tang CY, Wang H, Zhang Y, et al. GPR125 positively regulates osteoclastogenesis potentially through AKT-NF-κB and MAPK signaling pathways[J].Int J Biol Sci,2022,18(6):2392-2405.DOI:10.7150/ijbs.70620.
[10] Wei L, Chen W, Huang L, et al. Alpinetin ameliorates bone loss in LPS-induced inflammation osteolysis via ROS mediated P38/PI3K signaling pathway[J].Pharmacol Res,2022,184:106400.DOI:10.1016/j.phrs.2022.106400.
[11] Huang H, Jiang W, Hong K, et al. Protocatechualdehyde inhibits receptor activator of nuclear factor kappa-B ligand-induced osteoclastogenesis and attenuates lipopolysaccharide-induced inflammatory osteolysis[J].Phytother Res,2021,35(7):3821-3835.DOI:10.1002/ptr.7088.
[12] 陈翠霞,钱迪,郑伟昌,等. 破骨细胞分化因子及其相关因子在慢性化脓性中耳炎肉芽组织中的表达[J]. 青岛医药卫生,2022,54(1):6-11.DOI:10.3969/j.issn.1006-5571. 2022.01.002.
[13] Priyadarshi S, Ray CS, Biswal NC, et al. Genetic association and altered gene expression of osteoprotegerin in otosclerosis patients[J].Ann Hum Genet,2015,79(4):225-237.DOI:10.1111/ahg.12118.
[14] Potocka-Bakłażec M, Sakowicz-Burkiewicz M, Kuczkowski J, et al. Expression of TNF-α, OPG, IL-1β and the presence of the measles virus RNA in the stapes of the patients with otosclerosis[J].Eur Arch Otorhinolaryngol,2015,272(8):1907-1912.DOI:10.1007/s00405-014- 3008-4.
[15] Kuczkowski J, Sakowicz-Burkiewicz M, Iżycka-Świeszewska E. Expression of the receptor activator for nuclear factor-κB ligand and osteoprotegerin in chronic otitis media[J].Am J Otolaryngol,2010,31(6):404-409.DOI:10.1016/j.amjoto.2009.06.004.
[16] Massa HM, Spann KM, Cripps AW. Innate immunity in the middle ear mucosa[J].Front Cell Infect Microbiol,2021,11:764772.DOI:10.3389/fcimb.2021.764772.
[17] Seppanen EJ, Thornton RB, Corscadden KJ, et al. High concentrations of middle ear antimicrobial peptides and proteins and proinflammatory cytokines are associated with detection of middle ear pathogens in children with recurrent acute otitis media[J].PLoS One,2019,14(12):e0227080.DOI:10.1371/journal.pone.0227080.
[18] Artono, Surarto B, Purnami N, et al. The association of IL-1 alpha level and TNF alpha expressions on bone destruction in chronic suppurative otitis media and cholesteatoma[J].Indian J Otolaryngol Head Neck Surg,2020,72(1):1-7.DOI:10.1007/s12070-019-01704-z.
[19] Yetiser S, Satar B, Aydin N. Expression of epidermal growth factor, tumor necrosis factor-alpha, and interleukin-1alpha in chronic otitis media with or without cholesteatoma[J].Otol Neurotol,2002,23(5):647-652.DOI:10.1097/00129492-200209000-00007.
[20] Qu Y, Shen Y, Teng L, et al. Chicoric acid attenuates tumor necrosis factor-α-induced inflammation and apoptosis via the Nrf2/HO-1, PI3K/AKT and NF-κB signaling pathways in C28/I2 cells and ameliorates the progression of osteoarthritis in a rat model[J].Int Immunopharmacol,2022,111:109129.DOI:10.1016/j.intimp.2022.109129.
[21] Nason R, Jung JY, Chole RA. Lipopolysaccharide-induced osteoclastogenesis from mononuclear precursors: a mechanism for osteolysis in chronic otitis[J].J Assoc Res Otolaryngol,2009,10(2):151-160.DOI:10.1007/s10162-008-0153-8.
[22] Orecchioni M, Ghosheh Y, Pramod AB, et al. Macrophage polarization: different gene signatures in M1(LPS+) vs. classically and M2(LPS-) vs. alternatively activated macrophages[J].Front Immunol,2019,10:1084.DOI:10.3389/fimmu.2019.01084.
[23] Yunna C, Mengru H, Lei W, et al. Macrophage M1/M2 polarization[J].Eur J Pharmacol,2020,877:173090.DOI:10.1016/j.ejphar.2020.173090.
[24] Hume DA. The many alternative faces of macrophage activation[J].Front Immunol,2015,6:370.DOI:10.3389/fimmu.2015.00370.
[25] Bassiouni M, Arens P, Zabaneh SI, et al. The relationship between the M1/M2 macrophage polarization and the degree of ossicular erosion in human acquired cholesteatoma: an immunohistochemical study[J].J Clin Med,2022,11(16):4826.DOI:10.3390/jcm11164826.
[26] 方练,陈霖,林碧. 巨噬细胞表达基因在中耳胆脂瘤病理过程中的作用[J]. 温州医科大学学报,2021,51(5):352-357,363.DOI:10.3969/j.issn.2095-9400.2021.05.002.
[27] Jackler RK, Santa Maria PL, Varsak YK, et al. A new theory on the pathogenesis of acquired cholesteatoma: mucosal traction[J].Laryngoscope,2015,125 Suppl 4:S1-S14.DOI:10.1002/lary.25261.
[28] Alves AL, Pereira CS, Carvalho Mde F, et al. EGFR expression in acquired middle ear cholesteatoma in children and adults[J].Eur J Pediatr,2012,171(2):307-310.DOI:10.1007/s00431-011-1526-2.
[29] Xie S, Xiang Y, Wang X, et al. Acquired cholesteatoma epithelial hyperproliferation: Roles of cell proliferation signal pathways[J].Laryngoscope,2016,126(8):1923-1930.DOI:10.1002/lary.25834.
[30] Kuo CL, Shiao AS, Yung M, et al. Updates and knowledge gaps in cholesteatoma research[J].Biomed Res Int,2015,2015:854024.DOI:10.1155/2015/854024.
[31] Yamamoto-Fukuda T, Akiyama N, Shibata Y, et al. KGFR as a possible therapeutic target in middle ear cholesteatoma[J].Acta Otolaryngol,2014,134(11):1121-1127.DOI:10.3109/00016489.2014.907501. PMID: 25315911.
[32] Harabagiu OE, Cosgarea M, Mogoantă CA, et al. Keratinocyte growth factor and its receptor expression in chronic otitis media with and without cholesteatoma[J].Rom J Morphol Embryol,2017,58(4):1333-1338.